Hepatology

THE EUROPEAN Association for the Study of the Liver (EASL) Congress 2026 brought together the global hepatology community in..

THIS YEAR, at the European Association for the Study of the Liver (EASL) Congress, there were exciting new developments…

Non-invasive tests (NIT) were one of the strongest organising themes at the European Association for the Study of the Liver…

Primary liver cancers pose substantial clinical challenges despite significant advances in surveillance, diagnosis, and systemic therapy…

Primary biliary cholangitis (PBC) management in Europe has undergone a significant transition following the European Medicines Agency’s…

Drug-induced liver injury (DILI) remains a major adverse drug reaction and a leading cause of drug development failure and post-marketing…

MASLD IS now recognised as the most common chronic liver disease worldwide and a major contributor to liver-related morbidity and mortality…

Immune checkpoint inhibitors (ICI) targeting programmed cell death-1 (PD-1) and programmed death ligand-1 (PD-L1) have transformed the…